Mechanisms underlying the fertility and life-preserving cancer drugs.
Methods for cryopreservation (freezing), storing and growing ovarian and gonadal tissue.
In vitro follicle growth and oocyte maturation using a three-dimensional environment.
Communication barriers between cancer patients and health care providers.
Ethical and legal concerns regarding the use of fertility preservation technologies in cancer patients.
Make sure all parties involved from patients to caregivers, doctors to healthcare professionals, mainstream to media, know what to say and do when fertility is at risk.